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Pheochromocytoma is an endocrine tumor classically presenting with headache, paroxysmal hypertension, and palpitations. We
discuss the case of a young male, presenting with acute heart failure and cardiogenic shock requiring stabilization with an intra-
aortic balloon pump and a combination of ionotropes and vasopressors. Pheochromocytoma was diagnosed by CT scan, as
well as urine and plasma metanephrines. After pretreatment with phenoxy-benzamine, the patient underwent adrenalectomy
with subsequent cardiovascular stabilization and full recovery. Unfortunately, pheochromocytoma often remains undiagnosed.
Given the ample diagnostic tools and good prognosis when treated suitably, the diagnosis should be entertained early in patients,
presenting with unexplained cardiovascular compromise.
1.Introduction
Pheochromocytoma is an endocrine tumor typically located
in the adrenal glands which leads to catecholamine release
a n dp r o f o u n dm u l t i o r g a ni n v o l v e m e n t[ 1]. Typical symp-
toms include headache, palpitations, excessive sweating, and
intermittent or persistent hypertension. Other symptoms
such as abdominal pain, shock, respiratory distress syn-
drome, pulmonary edema, hyperthermia, and cardiogenic
shock occur less frequently [2–4]. The cardiovascular mani-
festationsofpheochromocytoma canalso includeelectrocar-
diographic changes, conduction disturbances, left ventricu-
lar hypertrophy, T-wave changes, and cardiac arrhythmias.
Apart from pheochromocytoma, catecholamine excess may
occur from stress, solvent abuse, overuse of adrenaline inhal-
er in patients with asthma, or prolonged amphetamine use
[5].
2.CaseReport
A 42-year-old Hispanic man presented to an outside hos-
pital with a history of diﬀuse and intermittent abdominal
discomfort, lasting minutes to hours. It was associated with
nausea, vomiting, and abdominal fullness. On the day of
presentation, he developed acute shortness of breath, dia-
phoresis, and epigastric discomfort.
IntheEmergencyDepartmentattheoutsidehospital,the
patient was found to be in acute respiratory distress with
severe hypoxemia, requiring emergent intubation. An EKG
revealed sinus tachycardia at 156 beats per minute, hypera-
cute T-waves in the anterior leads, and ST depressions infe-
riorly. Transthoracic echocardiography revealed an ejection
fraction (EF) of less than 20% with normal left ventric-
ular diastolic ﬁlling and normal valvular function. Right
ventricular size and function were normal, and there was
no pericardial eﬀusion. Emergent left heart catheterization
revealed normal coronary arteries, an EF of 15% with global
hypokinesis, and a left ventricular end-diastolic pressure of
45cm H20. During catheterization, he became profoundly
hypotensive (60s/30s) requiring a combination of pressors
and ionotropes as well as an intra-aortic balloon pump
(IABP) for additional cardiovascular support. Subsequently,
he was transferred to our cardiac intensive care unit for
further management.2 Case Reports in Medicine
Pertinent positives ﬁndings on transfer: intubated and
sedated thin man, temperature 36.8◦C, BP 110/90mmHg,
pulse130bpm,respirations 15/min,pulseoximetry 100%on
a ventilator. Pulmonary exam showed bilateral coarse breath
sounds with scattered rales. Cardiovascular exam revealed
a tachycardic, regular rhythm, with no murmurs, rubs, or
gallops, but jugular venous distention to the angle of the
mandible.
Laboratory studiesrevealed WBC 20,900/mcL,hemoglo-
bin 19g/dL, BUN 21mg/dL, creatinine 2.45mg/dL, glucose
74mg/dL, AST 616U/L, ALT 653U/L, alkaline phosphatase
185U/L, total bilirubin 1.9mg/dL, lactate 7mmol/L, BNP
488pg/mL, troponin I 69ng/mL, urine toxicology negative,
TSH 0.9mIU/mL, free thyroxine 1.1ng/mL, and HIV-1 and
2 antibody negative.
The patient was admitted to the cardiac intensive care
unit, and we continued cardiovascular support with a com-
bination of pressors and ionotropes as well as the IABP. A
chest ﬁlm revealed bibasilar inﬁltrates and a normal cardiac
silhouette. A transesophageal echo conﬁrmed the EF of 15%
with normal left ventricular diastolic ﬁlling and normal
valvular function and no signs of Takatsubo cardiomyopathy
present. As the patient remained minimally responsive to
therapy, a CT scan was ordered to exclude unrecognized
bleeding or an occult source of infection. The abdominal CT
scan without contrastrevealeda 9.2 × 7.6cm soft tissue mass
arising from the left adrenal gland (Figure 1).
Catecholaminesweredrawn,showing veryhighlyelevated
levels of epinephrine (24,186pg/mL, normal <84pg/mL)
and norepinephrine (24,691pg/mL, normal <420pg/mL)
with comparably less elevated levels of dopamine
(848pg/mL, normal <60pg/mL). Furthermore, urine and
plasma metanephrines were elevated 250-fold and 500-fold
over their respective normal ranges. Given these laboratory
and imaging ﬁndings, pheochromocytoma was considered
the most likely diagnosis. The patient was pretreated
with phenoxybenzamine for three days and underwent
uncomplicated adrenalectomy on hospital day seven. After
resection and pathological conﬁrmation of a pheochromo-
cytoma (Figure 2), the patient’s cardiovascular status rapidly
stabilized. Follow-up pan-CT did not reveal any metastatic
disease.Pressorsandionotropeswerediscontinued,theIABP
was removed, and the patient was successfully extubated.
A repeat echocardiogram on day twelve showed an EF of
45–50%.The patient was discharged on day 13 after near full
recovery to be followed up for genetic testing of Germ line
mutations, which came back negative.
3.Discussion
Pheochromocytoma is a great disease imitator. The classic
triadofheadache,palpitations,andparoxysmalhypertension
is not always present. Recognition requires a high index
of suspicion as it may present atypically including dilated
cardiomyopathy, pulmonary edema, sudden death, severe
sepsis, myocarditis, acute myocardial infarction, or, as in
this case, cardiogenic shock. This may at least partially
explain why is still a relatively uncommon diagnosis, despite
being present in up to 1:2,000 autopsies, as shown by a
retrospective study of 38,596 autopsies from Australia by
McNeil et al. [6]. In another retrospective study from the
Mayo Clinic, from the years from 1950 through 1979, 11
cases of pheochromocytoma were diagnosed in an average
populationof45,800[7].Thisrepresentsanannualincidence
rate of 0.8 nonfamilial pheochromocytomas per 100,000
person-years. Of those 11 cases, 5 were diagnosed initially at
autopsy [7]. These results are similar to the ones obtained
by the Swedish cancer registry, which found that 42% of
pheochromocytomas were ﬁrst diagnosed after death [8].
Weather all of the tumors discovered at autopsy are active
and clinically relevant remains unclear.
The pathogenesis of catecholamine-induced cardiomy-
opathy resulting in cardiogenic shock as seen with advanced
pheochromocytoma is multifactorial. Myocardial dysfunc-
tion duetocatecholamine-related injury ofmyocardial ﬁbers
appears to be the most common pathomechanism. Cate-
cholamines can cause tachycardia-induced cardiomyopathy
or may aggravate existing cardiac conditions [9]. Further-
more, excessive adrenergic stimulation may cause coronary
vasoconstriction and vasospasm, resulting in myocardial
ischemia and subsequent cardiomyopathy [10].
Catecholamines exert a receptor-mediated eﬀect on the
myocardium. Long-term elevation of catecholamine levels
lead to downregulation of beta-adrenergic receptors, thereby
inducing suboptimal functioning of myoﬁbers as well as a
decreased number of contracting units [5]. Furthermore,
oxidized catecholamines can increase sarcolemmal mem-
brane permeability, leading to calcium inﬂux and give
rise to profound changes in intracellular calcium mech-
anisms [11]. This can consequently result in an acute
myocarditis, with diﬀuse interstitial inﬂammatory inﬁltrates
and myocardial necrosis as well as decreased cardiac output.
In the presence of hypovolemia, decreased cardiac out-
put can culminate in cardiogenic shock [11], as seen in this
patient.
Early diagnosis remains diﬃcult in patients with atypical
presentations such as abdominal pain, respiratory distress,
pulmonary edema, hyperthermia, myocarditis, myocardial
infarction, or cardiogenic shock. In these patients, a high
index of suspicion is vital to timely diagnosis. In this case,
the patient’s history of intermittent abdominal pain led to an
early CT scan and discovery of the adrenal mass. Subsequent
acquisition of the highly elevated plasma catecholamines,
as well as urine and plasma metanephrines, reinforced the
working diagnosis of pheochromocytoma. Histology of the
tumor veriﬁed the diagnoses by showing the classical pattern
of pleomorphic cells with round hyperchromatic nuclei
and granular cytoplasm that are forming nests (zellballen)
surrounded by a ﬁbrovascular stroma. Malignant disease,
which can only be determined by metastatic spread of the
tumor was not present in our patient.
Treatment of pheochromocytoma initially focuses on
hemodynamic stabilization of the patient with aggressive
intravascular ﬂuid resuscitation as ﬁrst line therapy, comple-
mented by vasopressors and ionotropes as well as an IABP
for additional cardiovascular support if needed. This is then
followed by medical treatment with an alpha-blocker suchCase Reports in Medicine 3
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Figure 1: Noncontrast-enhanced abdominal CT scan showing the 9.2 × 7.6cm soft tissue mass arising from the left adrenal gland (white
arrow). (a) Transverse image, (b) Axial image.
(a) (b)
Figure 2: Microscopic images showing pathologic slides of the excised pheochromocytoma (a) Pheochromocytoma predominantly
consisting of pleomorphic chief cells with round, hyperchromatic nuclei (black arrow) adjacent to normal adrenal tissue (white arrow).
(b) Higher magniﬁcationshowingzellballen (nests)surrounded by a ﬁbrovascular stroma,with the cells showinga typical “saltand pepper”
chromatin and abundant granular amphophiliccytoplasm.
as phenoxybenzamine and a beta-blocker such as esmolol.
The alpha blocker should be started at a low dose and
uptitrated before initiation of beta-blocker therapy to avoid
unopposed alpha receptor stimulation by the excreted cate-
cholamines. This medical therapy reduces the risk of intra-
operative hemodynamic changes during tumor resection
[12, 13]. Furthermore, patients with sporadic pheochromo-
cytomashouldbeadvisedtoundergogenetictestingforgerm
line mutations to identify pheochromocytoma-associated
syndromes [14].
Unfortunately, pheochromocytoma remains undiag-
nosed in many patients presenting with atypical symptoms
despite adequate diagnostic tools, potentially leading to le-
thal outcomes. Given the ample treatment options that
greatly improve survival, it is essential to sustain a high index
of suspicion to entertain the diagnosis early in patients with
atypicalpresentationssuchasunexplainedacuteheartfailure
to improve the outcome for the individual patient.
4.Conclusion
Pheochromocytoma is a great disease imitator, and it re-
mains undiagnosed in many patients presenting with atyp-
ical symptoms—despite being present in up to 1:2,000
autopsies [6]. Recognition requires a high index of suspicion
as it may present atypically including dilated cardiomy-
opathy, pulmonary edema, sudden death, severe sepsis,
myocarditis, acute myocardial infarction, or, as in this case,
cardiogenic shock. Early diagnosis is essential to initiate ade-
quate therapy and reverse cardiomyopathy at an early stage.4 Case Reports in Medicine
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